HHS opens door to possibility of importing some drugs to drive down prices

WASHINGTON — The Trump administration is opening up the door to importing prescription drugs — at least in a limited number of cases.

The administration said Thursday that the Department of Health and Human Services will form a working group to look at the idea of importing drugs from other countries in cases in which there is a dramatic price increase for a drug produced by one manufacturer and not protected by patents or exclusivities.